When Immunity Backfires: Pembrolizumab-Induced Bilateral Pneumothorax in a Patient with Metastatic HPV-Associated Oropharyngeal Carcinoma
{{output}}
Background: Immune checkpoint inhibitors (ICIs) are standard therapy for recurrent or metastatic head and neck squamous cell carcinoma, but unleashing antitumour immunity can trigger immune-related adverse events (irAEs). Pneumot... ...
